Feb 12 (Reuters) - Medical products maker Baxter BAX.N forecast annual profit below Wall Street estimates on Thursday, due to persistent impact from hurricane-related disruptions at a key manufacturing unit.
Baxter expects 2026 adjusted profit between $1.85 and $2.05 per share, well below analysts' average expectation of $2.25 per share, according to data compiled by LSEG.
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))